Jilin Province Huinan Changlong Bio-pharmacy Company Limited
8049.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.36B
Close$
Share Statistics
| Market cap | $1.36 Billion |
|---|---|
| Enterprise Value | $1.15 Billion |
| Dividend Yield | $0.29 (11.87%) |
| Earnings per Share | $0.35 |
| Beta | 0.29 |
| Outstanding Shares | 560,250,000 |
Return
| Return on Equity | 15.38% |
|---|---|
| Return on Assets | 10.19% |
| Return on Invested Capital | 15.75% |
Valuation & Multiples
| P/E Ratio | 4.11 |
|---|---|
| PEG | 3.04 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 0.83 |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | 3.95 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jilin Province Huinan Changlong Bio-pharmacy Company Limited
1,107 employees
CEO: Hong Zhang Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive produc...